Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-022714
Filing Date
2021-02-16
Accepted
2021-02-16 07:02:08
Documents
1
Group Members
ROCHE HOLDING LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216688d3_sc13ga.htm SC 13G/A 67354
  Complete submission text file 0001104659-21-022714.txt   68916
Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Filed by) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: SC 13G/A

Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87213 | Film No.: 21632295
SIC: 2834 Pharmaceutical Preparations